4399在线视频免费观看

山(shan)(shan)東(dong)泰(tai)邦(bang)生(sheng)(sheng)(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)有限公(gong)司簡介(jie)山(shan)(shan)東(dong)泰(tai)邦(bang)生(sheng)(sheng)(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)有限公(gong)司是(shi)(shi)在山(shan)(shan)東(dong)省生(sheng)(sheng)(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)研(yan)究(jiu)所與外商于(yu)二00二年(nian)(nian)十一(yi)(yi)月成(cheng)立(li)的(de)(de)(de)合(he)(he)(he)資(zi)企(qi)(qi)業(ye)(ye)(ye)(ye)。是(shi)(shi)以(yi)(yi)血(xue)(xue)(xue)液(ye)(ye)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)、基因工程產(chan)(chan)(chan)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)和(he)生(sheng)(sheng)(sheng)(sheng)化(hua)(hua)(hua)制(zhi)(zhi)藥為主體的(de)(de)(de),集科研(yan)、生(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)、經營(ying)一(yi)(yi)體化(hua)(hua)(hua)的(de)(de)(de)重點高(gao)新技(ji)術企(qi)(qi)業(ye)(ye)(ye)(ye)。是(shi)(shi)山(shan)(shan)東(dong)定點的(de)(de)(de)國(guo)家血(xue)(xue)(xue)液(ye)(ye)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)生(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)企(qi)(qi)業(ye)(ye)(ye)(ye)。公(gong)司總部(bu)設在山(shan)(shan)東(dong)泰(tai)安(an)。在泰(tai)安(an)建(jian)有一(yi)(yi)個血(xue)(xue)(xue)液(ye)(ye)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)生(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)基地和(he)血(xue)(xue)(xue)液(ye)(ye)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)研(yan)究(jiu)中(zhong)心。公(gong)司現有人(ren)(ren)血(xue)(xue)(xue)白蛋(dan)(dan)白、人(ren)(ren)免(mian)(mian)疫(yi)(yi)球(qiu)(qiu)蛋(dan)(dan)白、靜注人(ren)(ren)免(mian)(mian)疫(yi)(yi)球(qiu)(qiu)蛋(dan)(dan)白（pH4）、乙型肝炎人(ren)(ren)免(mian)(mian)疫(yi)(yi)球(qiu)(qiu)蛋(dan)(dan)白、狂(kuang)犬(quan)病人(ren)(ren)免(mian)(mian)疫(yi)(yi)球(qiu)(qiu)蛋(dan)(dan)白、破(po)傷風人(ren)(ren)免(mian)(mian)疫(yi)(yi)球(qiu)(qiu)蛋(dan)(dan)白、人(ren)(ren)凝(ning)血(xue)(xue)(xue)因子Ⅷ、人(ren)(ren)凝(ning)血(xue)(xue)(xue)酶原復合(he)(he)(he)物(wu)、人(ren)(ren)纖維蛋(dan)(dan)白原等9個品(pin)(pin)(pin)(pin)(pin)(pin)(pin)種(zhong)，24個規(gui)格(ge)的(de)(de)(de)產(chan)(chan)(chan)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)，產(chan)(chan)(chan)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)批簽發合(he)(he)(he)格(ge)率100%，優質的(de)(de)(de)產(chan)(chan)(chan)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)贏(ying)得(de)了市(shi)場的(de)(de)(de)青(qing)睞。合(he)(he)(he)資(zi)以(yi)(yi)來，銷售收入(ru)年(nian)(nian)增(zeng)長率超過50%。泰(tai)邦(bang)生(sheng)(sheng)(sheng)(sheng)物(wu)成(cheng)立(li)六年(nian)(nian)來,生(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)經營(ying)迅速擴大(da),經濟取得(de)長足發展。企(qi)(qi)業(ye)(ye)(ye)(ye)的(de)(de)(de)綜合(he)(he)(he)實力(li)(li)從最初(chu)的(de)(de)(de)血(xue)(xue)(xue)液(ye)(ye)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)行業(ye)(ye)(ye)(ye)第(di)三梯(ti)隊(dui)(dui)上升(sheng)為第(di)一(yi)(yi)梯(ti)隊(dui)(dui)，產(chan)(chan)(chan)值利潤(run)等各項經濟指標(biao)統計(ji)的(de)(de)(de)綜合(he)(he)(he)實力(li)(li)排名,去年(nian)(nian)居全國(guo)血(xue)(xue)(xue)液(ye)(ye)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)同行業(ye)(ye)(ye)(ye)位列前(qian)3位。目前(qian)，公(gong)司擁有一(yi)(yi)支國(guo)際(ji)化(hua)(hua)(hua)的(de)(de)(de)管(guan)理團隊(dui)(dui)，其中(zhong)境外高(gao)管(guan)人(ren)(ren)士近半數，建(jian)立(li)起(qi)了與國(guo)際(ji)化(hua)(hua)(hua)運作相適應的(de)(de)(de)管(guan)理隊(dui)(dui)伍(wu)。2009年(nian)(nian)12月公(gong)司控股股東(dong)—China Biologic Products, Inc.（中(zhong)國(guo)生(sheng)(sheng)(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)）于(yu)美國(guo)納斯達(da)克成(cheng)功(gong)上市(shi)（交易(yi)代碼為NASDAQ:CBPO），為公(gong)司的(de)(de)(de)發展提(ti)供了強大(da)的(de)(de)(de)資(zi)本支持， 2009年(nian)(nian)9月，中(zhong)國(guo)生(sheng)(sheng)(sheng)(sheng)物(wu)制(zhi)(zhi)品(pin)(pin)(pin)(pin)(pin)(pin)(pin)從12000多家候選上市(shi)公(gong)司中(zhong)脫穎而出，榮登《福布(bu)斯》公(gong)布(bu)2009亞洲200家中(zhong)小企(qi)(qi)業(ye)(ye)(ye)(ye)榜(bang)單。